|
| Status |
Public on Jan 25, 2024 |
| Title |
Circulating microRNA analysis in a prospective co-clinical trial identifies biomarker of response and mechanisms of resistance to regorafenib in colorectal cancer |
| Organism |
Homo sapiens |
| Experiment type |
Non-coding RNA profiling by array
|
| Summary |
MicroRNA profiling was performed on baseline bloods using the NanoString nCounter platform in a serial liquid biopsies obtained at baseline in chemo-refractory mCRC patients treated with regorafenib in a phase II clinical trial (PROSPECT-R n=40; NCT03010722).
|
| |
|
| Overall design |
Examination of global miRNA expression profile in liquid biopsy of 40 chemo-refractory mCRC patients treated with regorafenib in a phase II clinical trial (PROSPECT-R n=40; NCT03010722)
|
| |
|
| Contributor(s) |
Cascione L, Valeri N |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Nov 27, 2023 |
| Last update date |
Jan 25, 2024 |
| Contact name |
Luciano Cascione |
| E-mail(s) |
luciano.cascione@ior.usi.ch
|
| Organization name |
IOR
|
| Department |
Lymphoma & Genomics Research Program
|
| Street address |
Via Chiesa 5
|
| City |
Bellinzona |
| State/province |
Ticino |
| ZIP/Postal code |
6500 |
| Country |
Switzerland |
| |
|
| Platforms (1) |
| GPL24158 |
NanoString nCounter Human v3 miRNA Assay (NS_H_miR_v3a) |
|
| Samples (40)
|
|
| Relations |
| BioProject |
PRJNA1045538 |
Less...
More...